PubMed

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.PMID: 17310045 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.

Bateman ED, van Dyk M, Sagriotis A.

Pulm Pharmacol Ther. 2008;21(1):20-5. Epub 2006 Oct 13.PMID: 17118684 [PubMed - indexed for MEDLINE]Related articles

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators.

N Engl J Med. 2007 Feb 22;356(8):775-89.PMID: 17314337 [PubMed - indexed for MEDLINE]Related articlesFree article

[Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease]

Baloira Villar A, Vilariño Pombo C.

Arch Bronconeumol. 2005 Mar;41(3):130-4. Spanish. PMID: 15766465 [PubMed - indexed for MEDLINE]Related articlesFree article

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. Epub 2007 Oct 4.PMID: 17916806 [PubMed - indexed for MEDLINE]Related articlesFree article

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.PMID: 15350163 [PubMed - indexed for MEDLINE]Related articles

Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.

Hodder R, Kesten S, Menjoge S, Viel K.

Int J Chron Obstruct Pulmon Dis. 2007;2(2):157-67.PMID: 18044688 [PubMed - indexed for MEDLINE]Related articlesFree article

Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.

Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y.

Respirology. 2009 Mar;14(2):239-44. Epub 2008 Dec 11.PMID: 19210650 [PubMed - indexed for MEDLINE]Related articles

Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.

Rabe KF, Timmer W, Sagkriotis A, Viel K.

Chest. 2008 Aug;134(2):255-62. Epub 2008 Apr 10.PMID: 18403672 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.

Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, Korducki L, Cassino C, Kesten S.

Ann Intern Med. 2005 Sep 6;143(5):317-26.PMID: 16144890 [PubMed - indexed for MEDLINE]Related articlesFree article

Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.

Nannini L, Cates CJ, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2004;(3):CD003794. Review. Update in: Cochrane Database Syst Rev. 2007;(4):CD003794. PMID: 15266502 [PubMed - indexed for MEDLINE]Related articles

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.

Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ Jr, Kesten S, Towse L.

Chest. 2002 Jul;122(1):47-55.PMID: 12114338 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.

Hanania NA, Boota A, Kerwin E, Tomlinson L, Denis-Mize K.

Drugs. 2009;69(9):1205-16. doi: 10.2165/00003495-200969090-00005.PMID: 19537837 [PubMed - indexed for MEDLINE]Related articles

A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD.

Cazzola M, Andò F, Santus P, Ruggeri P, Di Marco F, Sanduzzi A, D'Amato M.

Pulm Pharmacol Ther. 2007;20(5):556-61. Epub 2006 Jul 7.PMID: 16914336 [PubMed - indexed for MEDLINE]Related articles

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.

Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S.

Thorax. 2003 May;58(5):399-404. Erratum in: Thorax. 2005 Feb;60(2):105. PMID: 12728159 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.

Lapperre TS, Snoeck-Stroband JB, Gosman MM, Jansen DF, van Schadewijk A, Thiadens HA, Vonk JM, Boezen HM, Ten Hacken NH, Sont JK, Rabe KF, Kerstjens HA, Hiemstra PS, Timens W, Postma DS, Sterk PJ; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group.

Ann Intern Med. 2009 Oct 20;151(8):517-27.PMID: 19841453 [PubMed - indexed for MEDLINE]Related articles

A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.

Treat Respir Med. 2004;3(3):173-81.PMID: 15219176 [PubMed - indexed for MEDLINE]Related articles

Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease.

Nannini L, Lasserson TJ, Poole P.

Cochrane Database Syst Rev. 2003;(4):CD003794. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD003794. PMID: 14583994 [PubMed - indexed for MEDLINE]Related articles

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.

Fabbri LM, Calverley PM, Izquierdo-Alonso JL, Bundschuh DS, Brose M, Martinez FJ, Rabe KF; M2-127 and M2-128 study groups.

Lancet. 2009 Aug 29;374(9691):695-703.PMID: 19716961 [PubMed - indexed for MEDLINE]Related articles

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C; TRial of Inhaled STeroids ANd long-acting beta2 agonists study group.

Lancet. 2003 Feb 8;361(9356):449-56. Erratum in: Lancet. 2003 May 10;361(9369):1660. PMID: 12583942 [PubMed - indexed for MEDLINE]Related articles